Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)

National Institute of Neurological Disorders and Stroke (NINDS) · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
msmultiple-sclerosis
multiple sclerosis, rituximab, intrathecal, ms, secondary-progressive multiple sclerosis, sp-ms, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 810063
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.